Inhibition of brain glutamate carboxypeptidase II (GCPII) to enhance cognitive function Article Swipe
Robyn Wiseman
,
Kristin L. Bigos
,
Amy F.T. Arnsten
,
Barbara S. Slusher
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1016/bs.apha.2024.10.018
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1016/bs.apha.2024.10.018
Related Topics
Concepts
Glutamate receptor
Glutamate carboxypeptidase II
Neuroscience
Cognition
Chemistry
Brain function
Psychology
Biochemistry
Medicine
Internal medicine
Receptor
Prostate
Cancer
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1016/bs.apha.2024.10.018
- OA Status
- green
- Cited By
- 2
- References
- 164
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4404064640
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4404064640Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/bs.apha.2024.10.018Digital Object Identifier
- Title
-
Inhibition of brain glutamate carboxypeptidase II (GCPII) to enhance cognitive functionWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-11-05Full publication date if available
- Authors
-
Robyn Wiseman, Kristin L. Bigos, Amy F.T. Arnsten, Barbara S. SlusherList of authors in order
- Landing page
-
https://doi.org/10.1016/bs.apha.2024.10.018Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/12120972Direct OA link when available
- Concepts
-
Glutamate receptor, Glutamate carboxypeptidase II, Neuroscience, Cognition, Chemistry, Brain function, Psychology, Biochemistry, Medicine, Internal medicine, Receptor, Prostate, CancerTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2Per-year citation counts (last 5 years)
- References (count)
-
164Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4404064640 |
|---|---|
| doi | https://doi.org/10.1016/bs.apha.2024.10.018 |
| ids.doi | https://doi.org/10.1016/bs.apha.2024.10.018 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39929583 |
| ids.openalex | https://openalex.org/W4404064640 |
| fwci | 11.62666657 |
| mesh[0].qualifier_ui | Q000037 |
| mesh[0].descriptor_ui | D043425 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | antagonists & inhibitors |
| mesh[0].descriptor_name | Glutamate Carboxypeptidase II |
| mesh[1].qualifier_ui | Q000378 |
| mesh[1].descriptor_ui | D043425 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | metabolism |
| mesh[1].descriptor_name | Glutamate Carboxypeptidase II |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D006801 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Humans |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000818 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Animals |
| mesh[4].qualifier_ui | Q000187 |
| mesh[4].descriptor_ui | D003071 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | drug effects |
| mesh[4].descriptor_name | Cognition |
| mesh[5].qualifier_ui | Q000187 |
| mesh[5].descriptor_ui | D001921 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | drug effects |
| mesh[5].descriptor_name | Brain |
| mesh[6].qualifier_ui | Q000201 |
| mesh[6].descriptor_ui | D001921 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | enzymology |
| mesh[6].descriptor_name | Brain |
| mesh[7].qualifier_ui | Q000378 |
| mesh[7].descriptor_ui | D001921 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | metabolism |
| mesh[7].descriptor_name | Brain |
| mesh[8].qualifier_ui | Q000188 |
| mesh[8].descriptor_ui | D060825 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | drug therapy |
| mesh[8].descriptor_name | Cognitive Dysfunction |
| mesh[9].qualifier_ui | Q000037 |
| mesh[9].descriptor_ui | D043425 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | antagonists & inhibitors |
| mesh[9].descriptor_name | Glutamate Carboxypeptidase II |
| mesh[10].qualifier_ui | Q000378 |
| mesh[10].descriptor_ui | D043425 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | metabolism |
| mesh[10].descriptor_name | Glutamate Carboxypeptidase II |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D006801 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Humans |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000818 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Animals |
| mesh[13].qualifier_ui | Q000187 |
| mesh[13].descriptor_ui | D003071 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | drug effects |
| mesh[13].descriptor_name | Cognition |
| mesh[14].qualifier_ui | Q000187 |
| mesh[14].descriptor_ui | D001921 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | drug effects |
| mesh[14].descriptor_name | Brain |
| mesh[15].qualifier_ui | Q000201 |
| mesh[15].descriptor_ui | D001921 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | enzymology |
| mesh[15].descriptor_name | Brain |
| mesh[16].qualifier_ui | Q000378 |
| mesh[16].descriptor_ui | D001921 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | metabolism |
| mesh[16].descriptor_name | Brain |
| mesh[17].qualifier_ui | Q000188 |
| mesh[17].descriptor_ui | D060825 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | drug therapy |
| mesh[17].descriptor_name | Cognitive Dysfunction |
| mesh[18].qualifier_ui | Q000037 |
| mesh[18].descriptor_ui | D043425 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | antagonists & inhibitors |
| mesh[18].descriptor_name | Glutamate Carboxypeptidase II |
| mesh[19].qualifier_ui | Q000378 |
| mesh[19].descriptor_ui | D043425 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | metabolism |
| mesh[19].descriptor_name | Glutamate Carboxypeptidase II |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D006801 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Humans |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D000818 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Animals |
| mesh[22].qualifier_ui | Q000187 |
| mesh[22].descriptor_ui | D003071 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | drug effects |
| mesh[22].descriptor_name | Cognition |
| mesh[23].qualifier_ui | Q000378 |
| mesh[23].descriptor_ui | D001921 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | metabolism |
| mesh[23].descriptor_name | Brain |
| mesh[24].qualifier_ui | Q000187 |
| mesh[24].descriptor_ui | D001921 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | drug effects |
| mesh[24].descriptor_name | Brain |
| mesh[25].qualifier_ui | Q000188 |
| mesh[25].descriptor_ui | D060825 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | drug therapy |
| mesh[25].descriptor_name | Cognitive Dysfunction |
| mesh[26].qualifier_ui | Q000378 |
| mesh[26].descriptor_ui | D060825 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | metabolism |
| mesh[26].descriptor_name | Cognitive Dysfunction |
| mesh[27].qualifier_ui | Q000494 |
| mesh[27].descriptor_ui | D004791 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | pharmacology |
| mesh[27].descriptor_name | Enzyme Inhibitors |
| mesh[28].qualifier_ui | Q000627 |
| mesh[28].descriptor_ui | D004791 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | therapeutic use |
| mesh[28].descriptor_name | Enzyme Inhibitors |
| mesh[29].qualifier_ui | Q000037 |
| mesh[29].descriptor_ui | D043425 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | antagonists & inhibitors |
| mesh[29].descriptor_name | Glutamate Carboxypeptidase II |
| mesh[30].qualifier_ui | Q000378 |
| mesh[30].descriptor_ui | D043425 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | metabolism |
| mesh[30].descriptor_name | Glutamate Carboxypeptidase II |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D006801 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Humans |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D000818 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Animals |
| mesh[33].qualifier_ui | Q000187 |
| mesh[33].descriptor_ui | D003071 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | drug effects |
| mesh[33].descriptor_name | Cognition |
| mesh[34].qualifier_ui | Q000187 |
| mesh[34].descriptor_ui | D001921 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | drug effects |
| mesh[34].descriptor_name | Brain |
| mesh[35].qualifier_ui | Q000201 |
| mesh[35].descriptor_ui | D001921 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | enzymology |
| mesh[35].descriptor_name | Brain |
| mesh[36].qualifier_ui | Q000378 |
| mesh[36].descriptor_ui | D001921 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | metabolism |
| mesh[36].descriptor_name | Brain |
| mesh[37].qualifier_ui | Q000188 |
| mesh[37].descriptor_ui | D060825 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | drug therapy |
| mesh[37].descriptor_name | Cognitive Dysfunction |
| type | review |
| title | Inhibition of brain glutamate carboxypeptidase II (GCPII) to enhance cognitive function |
| biblio.issue | |
| biblio.volume | 102 |
| biblio.last_page | 63 |
| biblio.first_page | 27 |
| topics[0].id | https://openalex.org/T10077 |
| topics[0].field.id | https://openalex.org/fields/28 |
| topics[0].field.display_name | Neuroscience |
| topics[0].score | 0.9952999949455261 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2804 |
| topics[0].subfield.display_name | Cellular and Molecular Neuroscience |
| topics[0].display_name | Neuroscience and Neuropharmacology Research |
| topics[1].id | https://openalex.org/T10301 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9948999881744385 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Mitochondrial Function and Pathology |
| topics[2].id | https://openalex.org/T10086 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9941999912261963 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2737 |
| topics[2].subfield.display_name | Physiology |
| topics[2].display_name | Alzheimer's disease research and treatments |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C61174792 |
| concepts[0].level | 3 |
| concepts[0].score | 0.5972418189048767 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q420510 |
| concepts[0].display_name | Glutamate receptor |
| concepts[1].id | https://openalex.org/C20417620 |
| concepts[1].level | 4 |
| concepts[1].score | 0.5778643488883972 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q4140229 |
| concepts[1].display_name | Glutamate carboxypeptidase II |
| concepts[2].id | https://openalex.org/C169760540 |
| concepts[2].level | 1 |
| concepts[2].score | 0.45204076170921326 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q207011 |
| concepts[2].display_name | Neuroscience |
| concepts[3].id | https://openalex.org/C169900460 |
| concepts[3].level | 2 |
| concepts[3].score | 0.4307262599468231 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2200417 |
| concepts[3].display_name | Cognition |
| concepts[4].id | https://openalex.org/C185592680 |
| concepts[4].level | 0 |
| concepts[4].score | 0.4270074665546417 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[4].display_name | Chemistry |
| concepts[5].id | https://openalex.org/C3018390542 |
| concepts[5].level | 2 |
| concepts[5].score | 0.41831445693969727 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1073 |
| concepts[5].display_name | Brain function |
| concepts[6].id | https://openalex.org/C15744967 |
| concepts[6].level | 0 |
| concepts[6].score | 0.3116336464881897 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q9418 |
| concepts[6].display_name | Psychology |
| concepts[7].id | https://openalex.org/C55493867 |
| concepts[7].level | 1 |
| concepts[7].score | 0.21405553817749023 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[7].display_name | Biochemistry |
| concepts[8].id | https://openalex.org/C71924100 |
| concepts[8].level | 0 |
| concepts[8].score | 0.1980007290840149 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[8].display_name | Medicine |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.15718317031860352 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| concepts[10].id | https://openalex.org/C170493617 |
| concepts[10].level | 2 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[10].display_name | Receptor |
| concepts[11].id | https://openalex.org/C2776235491 |
| concepts[11].level | 3 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q9625 |
| concepts[11].display_name | Prostate |
| concepts[12].id | https://openalex.org/C121608353 |
| concepts[12].level | 2 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[12].display_name | Cancer |
| keywords[0].id | https://openalex.org/keywords/glutamate-receptor |
| keywords[0].score | 0.5972418189048767 |
| keywords[0].display_name | Glutamate receptor |
| keywords[1].id | https://openalex.org/keywords/glutamate-carboxypeptidase-ii |
| keywords[1].score | 0.5778643488883972 |
| keywords[1].display_name | Glutamate carboxypeptidase II |
| keywords[2].id | https://openalex.org/keywords/neuroscience |
| keywords[2].score | 0.45204076170921326 |
| keywords[2].display_name | Neuroscience |
| keywords[3].id | https://openalex.org/keywords/cognition |
| keywords[3].score | 0.4307262599468231 |
| keywords[3].display_name | Cognition |
| keywords[4].id | https://openalex.org/keywords/chemistry |
| keywords[4].score | 0.4270074665546417 |
| keywords[4].display_name | Chemistry |
| keywords[5].id | https://openalex.org/keywords/brain-function |
| keywords[5].score | 0.41831445693969727 |
| keywords[5].display_name | Brain function |
| keywords[6].id | https://openalex.org/keywords/psychology |
| keywords[6].score | 0.3116336464881897 |
| keywords[6].display_name | Psychology |
| keywords[7].id | https://openalex.org/keywords/biochemistry |
| keywords[7].score | 0.21405553817749023 |
| keywords[7].display_name | Biochemistry |
| keywords[8].id | https://openalex.org/keywords/medicine |
| keywords[8].score | 0.1980007290840149 |
| keywords[8].display_name | Medicine |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.15718317031860352 |
| keywords[9].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1016/bs.apha.2024.10.018 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S2764403048 |
| locations[0].source.issn | 1054-3589, 1557-8925 |
| locations[0].source.type | book series |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1054-3589 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Advances in pharmacology |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_lineage_names | Elsevier BV |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | book-chapter |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Advances in Pharmacology |
| locations[0].landing_page_url | https://doi.org/10.1016/bs.apha.2024.10.018 |
| locations[1].id | pmid:39929583 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Advances in pharmacology (San Diego, Calif.) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39929583 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:12120972 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Adv Pharmacol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12120972 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5071804120 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-4537-0473 |
| authorships[0].author.display_name | Robyn Wiseman |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I145311948 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD, United States. |
| authorships[0].institutions[0].id | https://openalex.org/I145311948 |
| authorships[0].institutions[0].ror | https://ror.org/00za53h95 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I145311948 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Johns Hopkins University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Robyn Wiseman |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD, United States. |
| authorships[1].author.id | https://openalex.org/A5083617820 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-5738-9008 |
| authorships[1].author.display_name | Kristin L. Bigos |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States; Department of Medicine, Division of Clinical Pharmacology, Johns Hopkins School of Medicine, Baltimore, MD, United States; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States. |
| authorships[1].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[1].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[1].institutions[1].id | https://openalex.org/I145311948 |
| authorships[1].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | Johns Hopkins University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Kristin L Bigos |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States; Department of Medicine, Division of Clinical Pharmacology, Johns Hopkins School of Medicine, Baltimore, MD, United States; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States. |
| authorships[2].author.id | https://openalex.org/A5019453928 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-3420-1308 |
| authorships[2].author.display_name | Amy F.T. Arnsten |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I32971472 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Neuroscience, Yale School of Medicine, New Haven, Connecticut, New Haven, CT, United States. |
| authorships[2].institutions[0].id | https://openalex.org/I32971472 |
| authorships[2].institutions[0].ror | https://ror.org/03v76x132 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I32971472 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Yale University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Amy F T Arnsten |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Neuroscience, Yale School of Medicine, New Haven, Connecticut, New Haven, CT, United States. |
| authorships[3].author.id | https://openalex.org/A5023686004 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-9814-4157 |
| authorships[3].author.display_name | Barbara S. Slusher |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I145311948 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD, United States; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, United States; Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD, United States; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, United States. Electronic address: [email protected]. |
| authorships[3].institutions[0].id | https://openalex.org/I145311948 |
| authorships[3].institutions[0].ror | https://ror.org/00za53h95 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I145311948 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Johns Hopkins University |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Barbara S Slusher |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD, United States; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, United States; Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD, United States; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, United States. Electronic address: [email protected]. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12120972 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Inhibition of brain glutamate carboxypeptidase II (GCPII) to enhance cognitive function |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10077 |
| primary_topic.field.id | https://openalex.org/fields/28 |
| primary_topic.field.display_name | Neuroscience |
| primary_topic.score | 0.9952999949455261 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2804 |
| primary_topic.subfield.display_name | Cellular and Molecular Neuroscience |
| primary_topic.display_name | Neuroscience and Neuropharmacology Research |
| related_works | https://openalex.org/W4396724950, https://openalex.org/W2110010918, https://openalex.org/W2983725837, https://openalex.org/W2126741950, https://openalex.org/W2021372044, https://openalex.org/W1981161260, https://openalex.org/W2510298210, https://openalex.org/W1580481741, https://openalex.org/W1983076548, https://openalex.org/W2937040465 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:12120972 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Adv Pharmacol |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12120972 |
| primary_location.id | doi:10.1016/bs.apha.2024.10.018 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S2764403048 |
| primary_location.source.issn | 1054-3589, 1557-8925 |
| primary_location.source.type | book series |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1054-3589 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Advances in pharmacology |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_lineage_names | Elsevier BV |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | book-chapter |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Advances in Pharmacology |
| primary_location.landing_page_url | https://doi.org/10.1016/bs.apha.2024.10.018 |
| publication_date | 2024-11-05 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W4220825176, https://openalex.org/W2012531942, https://openalex.org/W2114462462, https://openalex.org/W1595575260, https://openalex.org/W3112836681, https://openalex.org/W3093425074, https://openalex.org/W3109366202, https://openalex.org/W4212921746, https://openalex.org/W2131601310, https://openalex.org/W3108539410, https://openalex.org/W1984950849, https://openalex.org/W2133969927, https://openalex.org/W4205924630, https://openalex.org/W2171637628, https://openalex.org/W2045900488, https://openalex.org/W1495043122, https://openalex.org/W4392013406, https://openalex.org/W6857611131, https://openalex.org/W2013999515, https://openalex.org/W2005390537, https://openalex.org/W2072985930, https://openalex.org/W2052742260, https://openalex.org/W2021029707, https://openalex.org/W2491815092, https://openalex.org/W1998784857, https://openalex.org/W1969074641, https://openalex.org/W2020648457, https://openalex.org/W2150083064, https://openalex.org/W2163916026, https://openalex.org/W6869259906, https://openalex.org/W2972697535, https://openalex.org/W3214072887, https://openalex.org/W4387893908, https://openalex.org/W6859016123, https://openalex.org/W4398201684, https://openalex.org/W4211183388, https://openalex.org/W2146927157, https://openalex.org/W2105962778, https://openalex.org/W6635645843, https://openalex.org/W2034939822, https://openalex.org/W2036712372, https://openalex.org/W2322200216, https://openalex.org/W1995216212, https://openalex.org/W6676455349, https://openalex.org/W3107773165, https://openalex.org/W2158305615, https://openalex.org/W2107870182, https://openalex.org/W2146264275, https://openalex.org/W2031534534, https://openalex.org/W4297008497, https://openalex.org/W2044654696, https://openalex.org/W2132688053, https://openalex.org/W1975310412, https://openalex.org/W2594193621, https://openalex.org/W2251059370, https://openalex.org/W4200391132, https://openalex.org/W6678790002, https://openalex.org/W6629653124, https://openalex.org/W1994732080, https://openalex.org/W2110013817, https://openalex.org/W2081758723, https://openalex.org/W2028669320, https://openalex.org/W2134817799, https://openalex.org/W4386696908, https://openalex.org/W2573828241, https://openalex.org/W2475864443, https://openalex.org/W2152525754, https://openalex.org/W2073439757, https://openalex.org/W2028483524, https://openalex.org/W1977139958, https://openalex.org/W2591088516, https://openalex.org/W1994589100, https://openalex.org/W1980612042, https://openalex.org/W2616869905, https://openalex.org/W2078137220, https://openalex.org/W2278040574, https://openalex.org/W1979196482, https://openalex.org/W2428196131, https://openalex.org/W2002222551, https://openalex.org/W2288818676, https://openalex.org/W2913023902, https://openalex.org/W2087776102, https://openalex.org/W4366829188, https://openalex.org/W3034834420, https://openalex.org/W2797349527, https://openalex.org/W2044309727, https://openalex.org/W2741297243, https://openalex.org/W2594039838, https://openalex.org/W1983998585, https://openalex.org/W2117497657, https://openalex.org/W2130726599, https://openalex.org/W2169226763, https://openalex.org/W2592073683, https://openalex.org/W2072523602, https://openalex.org/W2766667582, https://openalex.org/W2772269246, https://openalex.org/W1976332633, https://openalex.org/W2155125375, https://openalex.org/W2162346026, https://openalex.org/W2085415566, https://openalex.org/W3023498751, https://openalex.org/W2139505125, https://openalex.org/W2739623469, https://openalex.org/W1520754465, https://openalex.org/W3186487554, https://openalex.org/W2102158590, https://openalex.org/W4361283182, https://openalex.org/W2743497962, https://openalex.org/W2109446991, https://openalex.org/W2295774726, https://openalex.org/W2101357408, https://openalex.org/W3000906016, https://openalex.org/W1978430524, https://openalex.org/W3208155427, https://openalex.org/W4793426, https://openalex.org/W1483485226, https://openalex.org/W4378675015, https://openalex.org/W4399972116, https://openalex.org/W3164868648, https://openalex.org/W2030584066, https://openalex.org/W2126261644, https://openalex.org/W4206371706, https://openalex.org/W1996126615, https://openalex.org/W4385273270, https://openalex.org/W1961027034, https://openalex.org/W2050583787, https://openalex.org/W3200523369, https://openalex.org/W2964169942, https://openalex.org/W2790728398, https://openalex.org/W2336613207, https://openalex.org/W1986834491, https://openalex.org/W2909170118, https://openalex.org/W2203125727, https://openalex.org/W4406061041, https://openalex.org/W4392200452, https://openalex.org/W2003656892, https://openalex.org/W4225367236, https://openalex.org/W2171217812, https://openalex.org/W1995830387, https://openalex.org/W2081986155, https://openalex.org/W1964435351, https://openalex.org/W2131685907, https://openalex.org/W2008873564, https://openalex.org/W2167224636, https://openalex.org/W2036574824, https://openalex.org/W2021814641, https://openalex.org/W1486910148, https://openalex.org/W4283383856, https://openalex.org/W4290786354, https://openalex.org/W2072934836, https://openalex.org/W2024829501, https://openalex.org/W2018148263, https://openalex.org/W4365484990, https://openalex.org/W1964238705, https://openalex.org/W2103515806, https://openalex.org/W3109298779, https://openalex.org/W2064676368, https://openalex.org/W4214956168, https://openalex.org/W4388071026, https://openalex.org/W2941461630, https://openalex.org/W4399353141, https://openalex.org/W4226195502, https://openalex.org/W4406030136, https://openalex.org/W2503555492 |
| referenced_works_count | 164 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 95 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| citation_normalized_percentile.value | 0.962 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |